Hims & Hers Health shares are trading higher amid possible sympathy with Novo Nordisk after the European Commission approved the company's once-daily Wegovy pill.

Benzinga Newsdesk www.benzinga.com Positive 95.3%

Neg 0% Neu 0% Pos 95.3%

Comments

No comments yet. Be the first!